Data as of November 13, 2026

Fenofibrate 134 mg Capsule

FENOFIBRATE

Brand: Fenofibrate

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$4.99/ fill$0.12 / EA
Cost Plus Drugs (retail)
$2.34/ fill$0.06 / EA
FUL
$5.01/ fill$0.12 / EA
AMP
$1.61/ fill$0.04 / EA
Medicaid FFS
$15.42/ fill
Medicaid MCO
$12.61/ fill

Sources: cms/nadac:price-ladder · costplusdrugs/price-list · cms/ful:generic-ceiling · cms/sdud. Cost Plus prices as of 2026-11-13

What's in the reimbursement

Ingredient cost (41.1 units/fill)$4.99
Dispensing fee & other (state-fixed, not margin)$10.43
Total reimbursed per fill$15.42

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 13 fee-for-service states, 28 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-10-28; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology